Investors know what's working and what's not. Jim Cramer says these stocks could power higher through the end of the year.
VIDEO ON MSN MONEY
Heavy selling pressure on weak economic data is bringing back memories of the market decline of March through May. Will it last?
Stocks and other risky assets had an ugly, ugly day Thursday as traders reacted so a batch of poor economic data out of China, Germany and the United States, as well as to lingering disappointment over the Federal Reserve's decision to merely extend its existing $400 billion Operation Twist initiative by $267 billion.
With Europe under pressure and growth slowing here, Wall Street obviously wanted more. So is that it? Is June's rebound finished? Not quite.
In a unanimous vote, government advisors said the benefits of a treatment for multiple myeloma outweigh the risks.
In an 11-0 vote, the panel of advisors said the benefits of the drug outweighed the risks for patients with multiple myeloma, a cancer of blood plasma cells.
Stocks slump on weak economic data from the US and China.
Chesapeake Energy (CHK) named former ConocoPhillips (COP) chairman Archie Dunham as its new chairman to replace Aubrey McClendon, who remains CEO and president. Chesapeake also appointed four new directors picked by its largest stakeholders, Southeastern Asset Management and Carl Icahn.
Philip Morris (PM) shares fell over 2% after the company became the latest multinational company to lower its full year 2012 earnings forecast.
Is a drop in the share price of the largest US chain of farm and ranch stores an opportunity?
But some analysts have warned of a possible slowing in demand from recreational farmers and ranchers for livestock and farm products, as well as for seasonal lawn and garden equipment amid a weakened economic recovery.
A company's exposure to Europe is becoming a red flag for many investors.
The ripples are spreading. Spanish consumers are buying cheaper yogurt, Europeans are buying fewer Volvos and Asians are consuming fewer chicken nuggets.
What it all adds up to is a steady drip-drip-drip of earnings pre-announcements and warnings from the multinational giants who once bet that having their tentacles in every corner of the globe would help them ride out recessions and other setbacks. This time, however, things may be different.
Under Armour is downgraded to 'neutral,' and ASML is initiated with an 'outperform.'
Thursday's noteworthy upgrades include:
- EQT Corporation (EQT) upgraded to Buy from Hold at Deutsche Bank
- Onyx Pharmaceuticals (ONXX) upgraded to Buy from Hold at Brean Murray, and to Outperform from Neutral at RW Baird
- TJX (TJX) upgraded to Outperform from Market Perform at Wells Fargo
- Vulcan Materials (VMC) upgraded to Positive from Neutral at Susquehanna
A higher life expectancy and rising retirement age are contributing to the boom in retirement solutions.
With doubts being raised about the solvency of the social security provision, Americans are encouraged to look for sources beyond government entitlement to secure their financial positions and avoid any chances of outliving their financial resources. The U.S. government has acknowledged that the official retirement age will rise from the current limit of 67 in the near future.
Bruce Berkowitz's Fairholme Fund is beginning to show some recovery signs in his long-term bets.
Berkowitz often emphasizes that he does not believe performance can be measured by a revolution of the sun but on a long-term basis. Though his fund suffered a challenging year, some of his long-term bets are beginning to show the recovery he anticipated.
CEO Bob McDonald must be held accountable for a string of poor quarterly results.
Why can't Bob McDonald be held accountable for what's happening at Procter & Gamble (PG)? Why can't the decline of this great company be placed at his feet?
A lot of people who write and talk about business do not, I believe, understand the importance of a CEO to an enterprise. They believe some companies can't really be affected in significant ways by the person at the helm.
Limited shipping capacity and strong demand are boosting prospects for this LNG tanker operator.
By Nathan Slaughter, Exploration & Paydirt
Golar LNG (GLNG) is one of the primary beneficiaries of the burgeoning global trade of liquefied natural gas (LNG).
The company owns a fleet of modern LNG tankers that are paid handsomely to transport chilled gas from port to port. Its fleet is 100% utilized, reflecting the lack of idle shipping capacity. Companies with available tonnage have almost been able to name their own price.
The stock's valuation makes it look too cheap not to take a bite.
By Dan Burrows
InvestorPlace's special report about Apple (AAPL) on the occasion of the iPhone's fifth birthday would surely be incomplete if we didn't weigh in on the prospects for its stock. Let's start by looking at how it's fared recently.
Turns out the shares have seriously stumbled since hitting a record closing high of $636 in early April. The stock is off more than 8% since then to about $580 and change, shedding $50 billion in market cap -- more than the entire value of Hewlett-Packard (HPQ) -- along the way.
That's a sharp sell-off. By comparison, the S&P 500 is off just 2% over the same period.
Orders from the US and Norway should benefit the company's aeronautics division.
The seventh batch will deliver 19 conventional take-off and landing or F-35 "A" models to the U.S. Air Force, six short take-off and vertical landing or F-35 "B" models to the U.S. Marine Corps, four carrier variants of F-35 to the U.S. Navy. The remaining six F-35 fighter planes will be delivered to some of the international partners of the F-35 JSF program, including three F-35 "A" models to Italy, two F-35 "A" models to Turkey and one F-35 "B" model to Britain.
The drugstore lowers sales guidance for the year, and the open source software provider reports weak billings.
Rite Aid (RAD) reported first-quarter earnings Thursday that met analysts' expectations, but it lowered its sales guidance for the year. The drugstore chain reported a first-quarter loss of $30.7 million, or 3 cents a share, narrower than a year-earlier loss of $65.5 million, or 7 cents a share. Analysts, on average, were expecting a loss of 3 cents a share.
Rite Aid lowered its fiscal 2013 sales guidance to between $25.3 billion and $25.7 billion and said it expects same-store sales to decline between 0.5% and 1%. The company previously anticipated sales would be between $25.4 billion and $25.8 billion with same-store sales between flat and an increase of 1.5%. Shares of Rite Aid fell 1.71% in premarket trading Thursday to $1.15.
Master limited partnerships constantly have to raise new money, which explains why Western Gas is selling 5 million units.
Investors hope the company has a next-generation treatment for the virus. The new data will fuel more takeover talk.
The stock rose 14.3% to close at $10.71. The shares have almost doubled in the past 12 months as investors bet that Idenix will be among the winners in developing a better treatment for the liver-destroying virus.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
The S&P 500 manages to keep a deathgrip on 2,000, but key areas of the market are already buckling under pressure.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The headlines generally favored Tuesday being another good day for the stock market. Instead, it was just a mixed day with modest point changes on either side of the unchanged mark for the major indices.
For the most part, the stock market was a sideshow. The main trading events were seen in the commodity and Treasury markets, both of which saw some decent-sized losses within their respective complex.
Dollar strength was at the heart of the weakness in ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|